Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 113

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 113
---
 statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.

/s/ J& S Associate PLT

Certified
Public Accountants

Firm
ID: 6743

We
have served as the Company’s auditor since 2024.

Kuala
Lumpur, Malaysia

April
29, 2025

  F-1  

Report
of Independent Registered Public Accounting Firm

To
the Shareholders and Board of Directors of EUDA Health Holdings Limited

Opinion
on the Financial Statements

We
have audited, before the effects of the adjustments to retrospectively apply the change in accounting described in Note 21, the accompanying
consolidated balance sheet of EUDA Health Holdings Limited (the “ Company”) as of December 31, 2023 and 2022, the related
consolidated statements of operations and comprehensive loss, changes in shareholders’ deficit and cash flows for each of two years
in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements” before
the effects of the adjustments discussed in Note 21 are not presented herein).

In
our opinion, the financial statements, before the effects of the adjustments to retrospectively apply the change in accounting described
in Note 21, present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results
of its operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles
generally accepted in the